In 4 posters presented at the Hematology/Oncology Pharmacy Association Annual Conference 2024, researchers addressed pharmacists’ role in managing patients’ anticancer medications.
Researchers highlighted the increasing scope of pharmacists’ ability to improve anticancer medication adherence and minimize adverse effects in multiple types of clinical settings. They also offered suggestions to implement specific pharmacist functions and ensure further mitigation of treatment disruptions.
The researchers addressed interventions from a health-system specialty pharmacy (HSSP), a pharmacist-led telehealth toxicity monitoring initiative, the monitoring of patients initiating poly ADP-ribose polymerase inhibitor (PARPi) therapy, and posttransplant vaccination compliance.
Read more of our coverage from the HOPA Annual Conference 2024.
Navigating Ethical, Financial Considerations When Delivering Cancer Care
April 30th 2024“I think in those situations where you can use the lower cost of the drug, you should, because it's going to help the overall societal perspective. That begins to break down, though, when that low-cost drug is the one that you're losing money on,” said Scott Soefje in a Q&A on balancing cost and margin at a site of care.